CLIMB BIO, INC. - Common Stock, par value $0.0001 per share (CLYM)

Historical Holders from Q3 2021 to Q3 2025

Symbol
CLYM on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
54,403,891
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
44,576,107
Holdings value
$89,598,934
% of all portfolios
0%
Number of holders
66
Number of buys
23
Number of sells
-45
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CLIMB BIO, INC. - Common Stock, par value $0.0001 per share (CLYM)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 33% $36,086,101 17,953,284 RA Capital Management, L.P. 11 Dec 2025
Pontifax Management 4 G.P. (2015) Ltd. 7.7% $12,911,822 5,206,380 Pontifax VI G.P. L.P. 27 Jun 2024

Institutional Holders of CLIMB BIO, INC. - Common Stock, par value $0.0001 per share (CLYM)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 44,576,107 $89,598,934 -$10,311,694 $2.01 66
2025 Q2 49,893,947 $61,871,600 -$2,503,034 $1.24 68
2025 Q1 51,939,064 $63,368,269 -$8,741,696 $1.22 76
2024 Q4 55,706,408 $100,272,719 -$19,354,214 $1.8 78
2024 Q3 54,655,767 $278,130,509 +$14,600,273 $5.09 69
2024 Q2 49,901,732 $354,801,793 +$245,093,722 $7.11 46
2024 Q1 16,855,387 $46,194,788 +$5,051 $2.74 20
2023 Q4 16,853,724 $45,505,627 +$348,407 $2.7 22
2023 Q3 16,728,590 $43,997,383 -$6,828 $2.63 22
2023 Q2 16,730,361 $46,844,345 +$79,298 $2.8 21
2023 Q1 16,702,070 $48,434,001 +$194,589 $2.9 19
2022 Q4 16,628,134 $61,000,699 +$90,854 $3.67 20
2022 Q3 14,807,225 $47,821,510 -$982,037 $3.23 20
2022 Q2 15,127,218 $45,689,000 -$21,553,504 $3.02 22
2022 Q1 17,488,772 $146,733,000 +$663,723 $8.39 40
2021 Q4 17,373,074 $181,720,000 +$142,325 $10.46 34
2021 Q3 17,279,112 $310,677,000 +$310,677,000 $17.98 31